Funding round
Kriya Therapeutics Series D
Kriya Therapeutics, which works in gene therapy research and development in Morrisville, raised $320M in a Series D round announced on 10 Sep 2025, led by Patient Square Capital and Premji Invest. 5 firms took part. It is Kriya Therapeutics' second venture round on record; the one before was a Series C in May 2022.
$320M
Amount raised
Not disclosed
Post-money valuation
5
Investors
2 leads
Valuation
What this round says about the price
Kriya Therapeutics did not disclose a valuation in this round. It came 40 months after Kriya Therapeutics' Series C. It is 54% of the $590M Kriya Therapeutics has raised in the venture rounds on record. No later venture round is on record for Kriya Therapeutics.
Kriya Therapeutics' funding rounds
Kriya Therapeutics has 2 venture rounds on record. This one is highlighted.
- Series C 16 May 2022, led by Patient Square Capital $270M
- Series D this round 10 Sep 2025, led by Patient Square Capital and Premji Invest $320M
Investors
Who put money in
Patient Square Capital and Premji Invest led the round with 3 other firms.
Lead investors
- backs 7 venture-backed companies new investor
- Premji Invest backs 50 venture-backed companies new investor
Also in the round
- backs 6 venture-backed companies new investor
- backs 15 venture-backed companies new investor
- Founders Fund backs 368 venture-backed companies new investor
Joined the board: Akshay Rai (Premji Invest).
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
13 Series D rounds in Biotechnology within a year either side disclosed an amount; the median was $97M, and this round was 3.3 times the median. The closest in time, other companies' Series D rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Enveda Biotechnology | 4 Sep 2025 | $150M | not disclosed | Premji Invest |
| Biotechnology | 30 Sep 2025 | $125M | not disclosed | Sanofi Ventures and Viking Global |
| Biotechnology | 24 Jun 2025 | $97M | not disclosed | healthcare investor |
| Biotechnology | 4 Jun 2025 | $50M | not disclosed | not named |
| Pathos Biotechnology | 15 May 2025 | $365M | $1.60B | not named |
| Biotechnology | 12 Mar 2025 | $35M | not disclosed | RA Capital |
| Biotechnology | 3 Mar 2025 | $700K | not disclosed | not named |
| Biotechnology | 8 Apr 2026 | $80M | not disclosed | not named |
Sources
Where this comes from
Reported by 3 sources.
Questions
Frequently asked
How much did Kriya Therapeutics raise in its Series D round?
Kriya Therapeutics raised $320M in its Series D round, announced in Sep 2025.
Who led Kriya Therapeutics' Series D round?
Patient Square Capital and Premji Invest led it, with Narya, T1D Fund and Founders Fund.
What was Kriya Therapeutics' valuation at the Series D round?
It was not disclosed.
How does it compare with other Series D rounds in Biotechnology?
13 Series D rounds in Biotechnology within a year either side disclosed an amount; the median was $97M, and this round was 3.3 times the median.